Sudbury, MA, United States of America

Benjamin D Enerson

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin D. Enerson

Introduction: Benjamin D. Enerson, an accomplished inventor based in Sudbury, MA, has made significant strides in the field of pharmaceuticals. With three patents to his name, his work focuses on the development of deuterated forms of testosterone and their potential applications in treating various medical conditions.

Latest Patents: Enerson's most notable patents include innovative compositions and methods involving deuterated testosterone and deuterated methyltestosterone. These pharmaceutical compositions offer promising solutions for treating a range of diseases and conditions such as hypogonadism, delayed growth and puberty, weight loss associated with HIV-related wasting, vulvar dystrophies, micropenis, breast cancer, and sexual disorders.

Career Highlights: Enerson currently works with Lennham Pharmaceuticals, Inc., where he continues to push the boundaries of medical research and development. His dedication to improving therapeutic options highlights his commitment to advancing healthcare through innovation.

Collaborations: Throughout his career, Enerson has collaborated with professionals in the field, including his coworker Bradford C. Sippy. Their joint efforts contribute to the ongoing advancement of pharmaceutical products that aim to enhance patient outcomes.

Conclusion: Benjamin D. Enerson stands out as a key figure in the realm of pharmaceutical innovation. His contributions through patenting novel compositions underscore the vital role inventors play in developing effective treatments and addressing pressing healthcare needs. As he continues his work at Lennham Pharmaceuticals, the impact of his inventions is sure to resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…